MINNEAPOLIS--(BUSINESS WIRE)--April 6, 2006--Urologix®, Inc. (NASDAQ:ULGX - News), has received permission, through the approval of three PMA supplements relating to new hardware and software, from the U.S. Food and Drug Administration to market its new CoolWave(TM) control unit. Urologix plans to launch CoolWave in the first quarter of fiscal 2007 (July-September), following select post-approval trials. A preview of CoolWave will be available in Urologix' booth at the 2006 AUA Annual Meeting in Atlanta.
